149 related articles for article (PubMed ID: 36749007)
1. Bullous periorbital oedema in anti-p155/140-positive dermatomyositis: a case series.
Connolly CM; Xu L; Mecoli CA; Adler BL; Tiniakou E; Albayda J; Christopher-Stine L; Paik JJ
Rheumatology (Oxford); 2023 Aug; 62(8):e237-e239. PubMed ID: 36749007
[No Abstract] [Full Text] [Related]
2. Clinical associations of autoantibodies to a p155/140 kDa doublet protein in juvenile dermatomyositis.
Gunawardena H; Wedderburn LR; North J; Betteridge Z; Dunphy J; Chinoy H; Davidson JE; Cooper RG; McHugh NJ;
Rheumatology (Oxford); 2008 Mar; 47(3):324-8. PubMed ID: 18238791
[TBL] [Abstract][Full Text] [Related]
3. Periorbital edema as the presenting sign of dermatomyositis.
Hall VC; Keeling JH; Davis MD
Int J Dermatol; 2003 Jun; 42(6):466-7. PubMed ID: 12786876
[TBL] [Abstract][Full Text] [Related]
4. Case report: A case of resistant anti-SAE1 dermatomyositis with severe periorbital edema after hydroxychloroquine that responded to adalimumab.
Farhat M; Soutou B
Int J Rheum Dis; 2024 Mar; 27(3):e15125. PubMed ID: 38501604
[No Abstract] [Full Text] [Related]
5. Detection of anti-p155/140, anti-p140, and antiendothelial cells autoantibodies in patients with juvenile dermatomyositis.
Yu HH; Chang HM; Chiu CJ; Yang YH; Lee JH; Wang LC; Lin YT; Chiang BL
J Microbiol Immunol Infect; 2016 Apr; 49(2):264-70. PubMed ID: 25070283
[TBL] [Abstract][Full Text] [Related]
6. Juvenile dermatomyositis presenting with periorbital edema.
Taban M; Perry JD
Ophthalmic Plast Reconstr Surg; 2006; 22(5):393-5. PubMed ID: 16985429
[TBL] [Abstract][Full Text] [Related]
7. Myositis autoantibodies in Korean patients with inflammatory myositis: anti-140-kDa polypeptide antibody is primarily associated with rapidly progressive interstitial lung disease independent of clinically amyopathic dermatomyositis.
Kang EH; Nakashima R; Mimori T; Kim J; Lee YJ; Lee EB; Song YW
BMC Musculoskelet Disord; 2010 Sep; 11():223. PubMed ID: 20875136
[TBL] [Abstract][Full Text] [Related]
8. Periorbital Edema in Dermatomyositis.
Connolly CM; Christopher-Stine L
N Engl J Med; 2023 Apr; 388(15):e52. PubMed ID: 37036143
[No Abstract] [Full Text] [Related]
9. A novel autoantibody to a 155-kd protein is associated with dermatomyositis.
Targoff IN; Mamyrova G; Trieu EP; Perurena O; Koneru B; O'Hanlon TP; Miller FW; Rider LG; ;
Arthritis Rheum; 2006 Nov; 54(11):3682-9. PubMed ID: 17075819
[TBL] [Abstract][Full Text] [Related]
10. Periorbital and facial swelling due to dermatomyositis.
Rafailidis PI; Kapaskelis A; Falagas ME
CMAJ; 2007 May; 176(11):1580-1. PubMed ID: 17515583
[No Abstract] [Full Text] [Related]
11. Periorbital edema as the presenting sign of juvenile dermatomyositis.
Sevigny GM; Mathes BM
Pediatr Dermatol; 1999; 16(1):43-5. PubMed ID: 10027999
[TBL] [Abstract][Full Text] [Related]
12. Association of p155/140 Autoantibody With Loss of Nailfold Capillaries but not Generalized Lipodystrophy: A Study of Ninety-Six Children With Juvenile Dermatomyositis.
Khojah A; Liu V; Savani SI; Morgan G; Shore R; Bellm J; Pachman LM
Arthritis Care Res (Hoboken); 2022 Jul; 74(7):1065-1069. PubMed ID: 33290639
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of anti-p155 autoantibody for diagnosing cancer-associated dermatomyositis: a systematic review and meta-analysis.
Trallero-Araguás E; Rodrigo-Pendás JÁ; Selva-O'Callaghan A; Martínez-Gómez X; Bosch X; Labrador-Horrillo M; Grau-Junyent JM; Vilardell-Tarrés M
Arthritis Rheum; 2012 Feb; 64(2):523-32. PubMed ID: 21953614
[TBL] [Abstract][Full Text] [Related]
14. NXP2-positive dermatomyositis complicated with refractory skin edema: Successful treatment with tocilizumab.
Lu Z; Chen Y; Xue J; Liu L
Dermatol Ther; 2021 Jan; 34(1):e14712. PubMed ID: 33368804
[No Abstract] [Full Text] [Related]
15. Medications received by patients with juvenile dermatomyositis.
Kishi T; Bayat N; Ward MM; Huber AM; Wu L; Mamyrova G; Targoff IN; Warren-Hicks WJ; Miller FW; Rider LG;
Semin Arthritis Rheum; 2018 Dec; 48(3):513-522. PubMed ID: 29773230
[TBL] [Abstract][Full Text] [Related]
16. The effect of cigarette smoking on the clinical and serological phenotypes of polymyositis and dermatomyositis.
Schiffenbauer A; Faghihi-Kashani S; O'Hanlon TP; Flegel WA; Adams SD; Targoff IN; Oddis CV; Ytterberg SR; Aggarwal R; Christopher-Stine L; Shamim EA; Dellaripa PF; Danoff SK; Mammen AL; Miller FW
Semin Arthritis Rheum; 2018 Dec; 48(3):504-512. PubMed ID: 29703532
[TBL] [Abstract][Full Text] [Related]
17. Subcutaneous oedema of upper limbs heralding an aggressive form of dermatomyositis.
Shukla M; Patel R; Kuzyshyn H; Feinstein D
BMJ Case Rep; 2018 May; 2018():. PubMed ID: 29848519
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and treatment of clinically amyopathic dermatomyositis (CADM): a case series and literature review.
Gil B; Merav L; Pnina L; Chagai G
Clin Rheumatol; 2016 Aug; 35(8):2125-2130. PubMed ID: 25846833
[TBL] [Abstract][Full Text] [Related]
19. Anti-MDA-5 negative, anti-Ku positive clinically amyopathic dermatomyositis.
Carrington AE; Tartar DM; Sivamani RK
Dermatol Online J; 2021 Apr; 27(4):. PubMed ID: 33999578
[TBL] [Abstract][Full Text] [Related]
20. INTERACTIVE MEDICAL CASE. Eye of the Beholder.
MacFarlane L; Osman N; Vaidya A; Amato AA; Ritter S
N Engl J Med; 2016 Apr; 374(15):e18. PubMed ID: 27074086
[No Abstract] [Full Text] [Related]
[Next] [New Search]
